Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin

IntroductionThis study investigated the tryptic hydrolysis of β-lactoglobulin (BLG) for 30, 60, 90, and 120 min at 1/200 E/S (enzyme/substrate ratio, w/w) to prepare potentially anticarcinogenic peptides.MethodsThe properties of hydrolysates were characterized, including degree of hydrolysis, free a...

Full description

Saved in:
Bibliographic Details
Main Authors: Eman Ibrahem, Ali Osman, Hefnawy Taha, Mohamed F. Abo El-Maati, Basel Sitohy, Mahmoud Sitohy
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2024.1444457/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550148445929472
author Eman Ibrahem
Ali Osman
Hefnawy Taha
Mohamed F. Abo El-Maati
Basel Sitohy
Basel Sitohy
Mahmoud Sitohy
author_facet Eman Ibrahem
Ali Osman
Hefnawy Taha
Mohamed F. Abo El-Maati
Basel Sitohy
Basel Sitohy
Mahmoud Sitohy
author_sort Eman Ibrahem
collection DOAJ
description IntroductionThis study investigated the tryptic hydrolysis of β-lactoglobulin (BLG) for 30, 60, 90, and 120 min at 1/200 E/S (enzyme/substrate ratio, w/w) to prepare potentially anticarcinogenic peptides.MethodsThe properties of hydrolysates were characterized, including degree of hydrolysis, free amino acids, SDS-PAGE, FTIR, and antioxidant activity employing DPPH-assay, β-carotene/linoleic acid, and FRAP assay.ResultsBLG tryptic hydrolysate produced after 60 min hydrolysis recorded the highest antioxidant activity, and LCMS analysis revealed 162 peptides of molecular masses ranging from 800 to 5671Da, most of them are of hydrophobic nature. Within the low-MW peptide group (24 peptides), there were nine hydrophobic basic (HB) and seven hydrophobic acidic (HA), representing 38% and 29%, respectively. The HB peptides may be responsible for the considerable biological activity of the hydrolysate. With dominant basic character supporting the carcinogenic activity of this hydrolysate. The in vitro anticancer activity against Mcf-7, Caco-2, and A-549 human cancer cell lines proliferation by MTT assay recorded IC50% at 42.8, 76.92, and 45.93 μg/mL, respectively. Treating each cell line with IC50% of the hydrolysate for 24 h increased the apoptosis by enhancing the expression of caspase-9 by 5.66, 7.97, and 3.28 folds over the untreated control and inhibited angiogenesis by reducing VEGFR-2 expression by about 56, 76, and 70%, respectively, indicating strong anticancer and antiangiogenic actions on human cancer cells. BLG tryptic hydrolysate may serve as a natural anticarcinogenic agent. The results of this study demonstrated that BLG hydrolysates have direct anticancer and antiangiogenic effects on human cancer cells. The chemical composition and characteristics of the BLG tryptic hydrolysate influence these biological and anticancer activities. The tryptic hydrolysates were generally effective against the three cancer cell lines studied (Mcf-7, Caco-2, and A-549). This effectiveness was assessed by measuring cell proliferation using the MTT assay and by evaluating their impact on angiogenesis through inhibition of VEGFR-2 activity.DiscussionFuture studies may focus on enhancing the anticarcinogenic effectiveness of the peptides by isolating and evaluating the most prominent individual peptide and varying the treatment conditions.
format Article
id doaj-art-eab3404fdf954dbdaac56fd515080ade
institution Kabale University
issn 2296-889X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj-art-eab3404fdf954dbdaac56fd515080ade2025-01-10T07:46:52ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2025-01-011110.3389/fmolb.2024.14444571444457Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulinEman Ibrahem0Ali Osman1Hefnawy Taha2Mohamed F. Abo El-Maati3Basel Sitohy4Basel Sitohy5Mahmoud Sitohy6Department of Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, EgyptDepartment of Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, EgyptDepartment of Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, EgyptDepartment of Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, EgyptDepartment of Clinical Microbiology, Infection and Immunology, Umeå University, Umeå, SwedenDepartment of Diagnostics and Intervention, Oncology, Umeå University, Umeå, SwedenDepartment of Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, EgyptIntroductionThis study investigated the tryptic hydrolysis of β-lactoglobulin (BLG) for 30, 60, 90, and 120 min at 1/200 E/S (enzyme/substrate ratio, w/w) to prepare potentially anticarcinogenic peptides.MethodsThe properties of hydrolysates were characterized, including degree of hydrolysis, free amino acids, SDS-PAGE, FTIR, and antioxidant activity employing DPPH-assay, β-carotene/linoleic acid, and FRAP assay.ResultsBLG tryptic hydrolysate produced after 60 min hydrolysis recorded the highest antioxidant activity, and LCMS analysis revealed 162 peptides of molecular masses ranging from 800 to 5671Da, most of them are of hydrophobic nature. Within the low-MW peptide group (24 peptides), there were nine hydrophobic basic (HB) and seven hydrophobic acidic (HA), representing 38% and 29%, respectively. The HB peptides may be responsible for the considerable biological activity of the hydrolysate. With dominant basic character supporting the carcinogenic activity of this hydrolysate. The in vitro anticancer activity against Mcf-7, Caco-2, and A-549 human cancer cell lines proliferation by MTT assay recorded IC50% at 42.8, 76.92, and 45.93 μg/mL, respectively. Treating each cell line with IC50% of the hydrolysate for 24 h increased the apoptosis by enhancing the expression of caspase-9 by 5.66, 7.97, and 3.28 folds over the untreated control and inhibited angiogenesis by reducing VEGFR-2 expression by about 56, 76, and 70%, respectively, indicating strong anticancer and antiangiogenic actions on human cancer cells. BLG tryptic hydrolysate may serve as a natural anticarcinogenic agent. The results of this study demonstrated that BLG hydrolysates have direct anticancer and antiangiogenic effects on human cancer cells. The chemical composition and characteristics of the BLG tryptic hydrolysate influence these biological and anticancer activities. The tryptic hydrolysates were generally effective against the three cancer cell lines studied (Mcf-7, Caco-2, and A-549). This effectiveness was assessed by measuring cell proliferation using the MTT assay and by evaluating their impact on angiogenesis through inhibition of VEGFR-2 activity.DiscussionFuture studies may focus on enhancing the anticarcinogenic effectiveness of the peptides by isolating and evaluating the most prominent individual peptide and varying the treatment conditions.https://www.frontiersin.org/articles/10.3389/fmolb.2024.1444457/fullβ-lactoglobulintrypsinantioxidant activityanticancer activitycaspaseVEGFR-2
spellingShingle Eman Ibrahem
Ali Osman
Hefnawy Taha
Mohamed F. Abo El-Maati
Basel Sitohy
Basel Sitohy
Mahmoud Sitohy
Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
Frontiers in Molecular Biosciences
β-lactoglobulin
trypsin
antioxidant activity
anticancer activity
caspase
VEGFR-2
title Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
title_full Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
title_fullStr Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
title_full_unstemmed Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
title_short Anticarcinogenic cationic peptides derived from tryptic hydrolysis of β-lactoglobulin
title_sort anticarcinogenic cationic peptides derived from tryptic hydrolysis of β lactoglobulin
topic β-lactoglobulin
trypsin
antioxidant activity
anticancer activity
caspase
VEGFR-2
url https://www.frontiersin.org/articles/10.3389/fmolb.2024.1444457/full
work_keys_str_mv AT emanibrahem anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT aliosman anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT hefnawytaha anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT mohamedfaboelmaati anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT baselsitohy anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT baselsitohy anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin
AT mahmoudsitohy anticarcinogeniccationicpeptidesderivedfromtryptichydrolysisofblactoglobulin